Chromosome aberrations among cigarette smokers in Colombia

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 562, Issue 1-2, 2004, Pages 67-75

  Sierra Torres, Monica S ^a,b   Arboleda Moreno, Yexania Y ^b,c   Hoyos, Luz S ^b   Sierra Torres, Carlos H ^c  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b Fac Cie Nat Exact Y E   (Colombia)

^c UNIVERSIDAD DEL CAUCA   (Colombia)

Author keywords

Chromosome aberrations; Colombia; Genotoxicity; Smoking

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL CULTURE; CHROMOSOME ABERRATION; CIGARETTE SMOKING; COLOMBIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; INFORMED CONSENT; LYMPHOCYTE; MALE; METAPHASE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADOLESCENT; ADULT; CHROMOSOME ABERRATIONS; COLOMBIA; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING;

NICOTIANA TABACUM;

EID: 3242773003     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.05.006     Document Type: Article

References (39)

1. World Health Organization, The World Health Report 2002: Reducing Risks, Extending Healthy Life, WHO, Geneva, 2002.
2. da Costa e Silva V., Koifman S. Smoking in Latin America: a major public health problem. Cad. Saude Publica. 14(Suppl. 3):1998;99-108
3. Ramsay S. PAHO exposes tobacco-industry tactics in Latin America. Pan American Health Organization. Lancet. 360:2002;2057
4. Corrao M.A., Guindon G.E., Cokkinides V., Sharma N. Building the evidence base for global tobacco control. Bull. World. Health Organ. 78:2000;884-890
5. RUMBOS, Programa presidencial para afrontar el consumo de drogas, Sondeo nacional del consumo de drogas en jóvenes, Disponible en internet: http://www.presidencia.gov.co/rumbos/sondeo/frgusond.htm, March 10, 2002.
6. International Agency for Research on Cancer, Monograph on the evaluation of the carcinogenic risk of chemicals to humans, IARC Sci. Publ. 38 (1986) 1-421.
7. Weir H.K., Thun M.J., Hankey B.F., Ries L.A., Howe H.L., Wingo P.A., Jemal A., Ward E., Anderson R.N., Edwards B.K. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl. Cancer Inst. 95:2003;1276-1299
8. Fagerstrom K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs. 62(Suppl. 2):2002;1-9
9. Au W.W., Cajas-Salazar N., Salama S. Factors contributing to discrepancies in population monitoring studies. Mutat. Res. 400:1998;467-478
10. Bonassi S., Hagmar L., Stromberg U., Montagud A.H., Tinnerberg H., Forni A., Heikkila P., Wanders S., Wilhardt P., Hansteen I.L., Knudsen L.E., Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 60:2000;1619-1625
11. Rutherford A.J., Shillito J. The patient with recurrent miscarriage. Practitioner. 246:2002;342-349
12. Bonassi S., Au W.W. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511:2002;73-86
13. Bender M.A., Preston R.J., Leonard R.C., Pyatt B.E., Gooch P.C., Shelby M.D. Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. Mutat. Res. 204:1988;421-433
14. Nordic Study Group on the Health Risk of Chromosome Damage, A Nordic data base on somatic chromosome damage in humans, Mutat. Res. 241 (1990) 325-337.
15. Littlefield L.G., Joiner E.E. Analysis of chromosome aberrations in lymphocytes of long-term heavy smokers. Mutat. Res. 170:1986;145-150
16. Sinues B., Izquierdo M., Perez V.J. Chromosome aberrations and urinary thioethers in smokers. Mutat. Res. 240:1990;289-293
17. Jin Y.L., Wang H.Z., Gu H. Observation of chromosome aberration and micronucleus formation in peripheral blood lymphocytes among cigarette smokers. Zhonghua Liu Xing Bing Xue Za Zhi. 18:1997;40-42
18. Tawn E.J., Whitehouse C.A. Frequencies of chromosome aberrations in a control population determined by G banding. Mutat. Res. 490:2001;171-177
19. World Medical Association, The Helsinki declaration, Orv. Hetil. 106 (1965) 1715-1716.
20. Sierra-Torres C.H., Au W.W., Arrastia C.D., Cajas-Salazar N., Robazetti S.C., Payne D.A., Tyring S.K. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ. Mol. Mutagen. 41:2003;69-76
21. Hoyos L.S., Carvajal S., Solano L., Rodriguez J., Orozco L., Lopez Y., Au W.W. Cytogenetic monitoring of farmers exposed to pesticides in Colombia. Environ. Health Perspect. 104(Suppl. 3):1996;535-538
22. Goto K., Akematsu T., Shimazu H., Sugiyama T. Simple differential Giemsa staining of sister chromatids after treatment with photosensitive dyes and exposure to light and the mechanism of staining. Chromosoma. 53:1975;223-230
23. Whorton E.B.J. Some experimental design and analysis considerations for cytogenetics studies. Environ. Mutagen. 7(Suppl. 4):1985;9-15
24. Deland K., Lewis K., Taylor A.L. Developing a public policy response to the tobacco industry's targeting of women and girls: the role of the WHO Framework Convention on Tobacco Control. J. Am. Med. Women's Assoc. 55:2000;316-319
25. Deland K., Lewis K., Taylor A.L. Developing a public policy response to the tobacco industry's targeting of women and girls: the role of the WHO Framework Convention on Tobacco Control. J. Am. Med. Women's Assoc. 55:2000;321
26. Taylor A.L., Bettcher D.W. WHO Framework Convention on Tobacco Control: a global "good" for public health. Bull. World Health Organ. 78:2000;920-929
27. Au W.W., Walker D.M., Ward J.B.J., Whorton E., Legator M.S., Singh V. Factors contributing to chromosome damage in lymphocytes of cigarette smokers. Mutat. Res. 260:1991;137-144
28. el-Zein R., Zwischenberger J.B., Wood T.G., Abdel-Rahman S.Z., Brekelbaum C., Au W.W. Combined genetic polymorphism and risk for development of lung cancer. Mutat. Res. 381:1997;189-200
29. Cajas-Salazar N., Au W.W., Zwischenberger J.B., Sierra-Torres C.H., Salama S.A., Alpard S.K., Tyring S.K. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. Cancer Genet. Cytogenet. 145:2003;97-102
30. Conforti-Froes N., el-Zein R., Abdel-Rahman S.Z., Zwischenberger J.B., Au W.W. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat. Res. 379:1997;53-59
31. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat. Res. 114:1983;59-89
32. M. Sorsa, Experimental studies on the mutagenicity and related effects of low-tar and high-tar cigarettes in relation to smoker exposures, IARC Sci. Publ. (1986) 227-235.
33. Bonassi S., Neri M., Lando C., Ceppi M., Lin Y.P., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Fenech M. Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project. Mutat. Res. 543:2003;155-166
34. Colombia Health Profile. In: Pan American Health Organization (Ed.), Health in the Americas, vol. II, Washington, DC, 1998, pp. 181-193.
35. Ministerio de Salud, Segundo estudio nacional de factores de riesgo de enfermedades crónicas, 1998.
36. Salama S.A., Abdel-Rahman S.Z., Sierra-Torres C.H., Hamada F.A., Au W.W. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics. 9:1999;735-743
37. Salama S.A., Sierra-Torres C.H., Oh H.Y., Hamada F.A., Au W.W. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ. Mol. Mutagen. 37:2001;17-26
38. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 18:1996;188-204
39. Shibuya K., Ciecierski C., Guindon E., Bettcher D.W., Evans D.B., Murray C.J. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ. 327:2003;154-157